Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| RAYZEBIO INC | 5,158,162 | 5,158,162 | 0 | 114,511 | 320,683 | 48.06% | +206,172 |
| ALX ONCOLOGY HLDGS INC(ALXO) | 9,699,925 | 9,699,925 | 0 | 46,560 | 144,432 | 21.65% | +97,872 |
| PHARVARIS N V COM | 4,264,672 | 4,919,504 | +654,832 | 89,004 | 137,992 | 20.68% | +48,988 |
| ELEVATION ONCOLOGY INC | 2,914,255 | 2,914,255 | 0 | 1,931 | 1,565 | 0.23% | -366 |
| HARMONY BIOSCIENCES HLDGS IN(HRMY) | 1,035,396 | 1,035,396 | 0 | 33,930 | 33,443 | 5.01% | -487 |
| IMPEL PHARMACEUTICALS INC | 2,759,791 | 2,759,791 | 0 | 1,187 | 341 | 0.05% | -846 |
| ACELYRIN INC | 3,852,470 | 3,852,470 | 0 | 39,180 | 28,739 | 4.31% | -10,440 |
| VENTYX BIOSCIENCES INC | 758,800 | 0 | -758,800 | 26,353 | 0 | — | -26,353 |